A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
BA-2664
Piperidolate
The risk or severity of adverse effects can be increased when Revefenacin is combined with Piperidolate.
BA-2664
Prifinium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Prifinium.
BA-2664
Tropatepine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Tropatepine.
BA-2664
Mebeverine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Mebeverine.
BA-2664
Batefenterol
The risk or severity of adverse effects can be increased when Revefenacin is combined with Batefenterol.
BA-2664
Propiverine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Propiverine.
BA-2664
Oxitropium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Oxitropium.
BA-2664
Methscopolamine
The risk or severity of adverse effects can be increased when Methscopolamine is combined with Revefenacin.
BA-2664
Thonzylamine
The risk or severity of adverse effects can be increased when Thonzylamine is combined with Revefenacin.
BA-2664
Homatropine
The risk or severity of adverse effects can be increased when Homatropine is combined with Revefenacin.
BA-2664
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Revefenacin.
BA-2664
Imidafenacin
The risk or severity of adverse effects can be increased when Imidafenacin is combined with Revefenacin.
BA-2664
Trimebutine
The risk or severity of adverse effects can be increased when Trimebutine is combined with Revefenacin.
BA-2664
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Revefenacin.
BA-2664
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Revefenacin.
BA-2664
Dimetindene
The risk or severity of adverse effects can be increased when Dimetindene is combined with Revefenacin.
BA-2664
Hexocyclium
The risk or severity of adverse effects can be increased when Hexocyclium is combined with Revefenacin.
BA-2664
Mepenzolate
The risk or severity of adverse effects can be increased when Mepenzolate is combined with Revefenacin.
BA-2664
Isopropamide
The risk or severity of adverse effects can be increased when Isopropamide is combined with Revefenacin.
BA-2664
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Revefenacin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3